The 2017 Kidney Disease: Improving Global Outcomes (KDIGO) guideline on the management of chronic kidney disease-mineral bone disorder (CKD-MBD) suggests measuring serum calcium and serum phosphate every one to three months and serum parathyroid hormone (PTH) every three to six months. Here, PTH is linked to abnormal mineralization disorder.